top of page
Search

ART-TG at ESGCT 2025 in Seville

  • ART-TG
  • Oct 3
  • 2 min read

Updated: Oct 6

ree

The ART-TG is proud to announce its participation in the upcoming ESGCT Annual Congress, taking place in Seville from October 7–10, 2025 !

This year, our teams are proud to be represented in 1 Education session presented by our Research Director Dr. Anne GALY, 6 posters and 2 oral presentations covering a wide range of innovative projects and strong collaborations in the gene therapy field.


Education session

Tuesday October 7th, 2025

EDUCATION SESSION 1a - Gene delivery: going viral and non-viral (9h30)

  • EDU02: Insights on the lentivirus vector system, Dr. Anne GALY


Poster session :

Wednesday October 8th, 2025

  • P0437 – Scalisi et al., Novel homology-mediated end joining-IDLV precise integration for Therapeutic Genome Editing in Hematopoietic Stem Cells

  • P0803 – Dewannieux et al. , Analyzing the combined effects of pseudotype and transduction adjuvants on restriction factors, to improve lentiviral vector gene transfer efficacy in primary cells.


Thursday October 9th, 2025

  • P0784 – Fournier et al., Production and characterization of anti-HIV broadly-neutralizing antibodies in human B cells

  • P0788 – Magrin et al, The DREPAMIR clinical trial for patients with sickle cell disease : preclinical results

  • P0830 – Fournier et al. Characterization of lentiviral standards and their use for the quality control of gene-modified cells.

  • P0884 – Habtoun et al. A Web App for Viral Vector Production Downstream Processing Analytics by Knowledge Graph and LLM Technology


Oral presentations :

Friday October 10th, 2025 Session 12d: Hematopoietic & PID II (11h-12h45)

  • OR100 – Lagresle-Peyrou et al. Ex-vivo gene therapy for Artemis deficiency : results of the French ARTEGENE phase I/II clinical trial

  • OR102 – Semeraro et al. From Cure to Flare : Targeting Post-Gene Therapy Inflammation in Wiskott Aldrich syndrome


We look forward to sharing our advances, exchanging with the community, and contributing to the progress of gene therapy research.

Find out more about the program : https://www.esgctcongress.com/programme


 
 
 

Comments


ART-TG
Inserm US35
30 rue H. Desbruères
91100 Corbeil-Essonnes
France

Director :
Anne Galy PhD

Copyright @ ART-TG 2021

bottom of page